Emmessar Biotech & Nutrition Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 48.834 million compared to INR 12.314 million a year ago. Operating income was INR 13.26 million compared to INR 1.912 million a year ago. Net income was INR 5.157 million compared to net loss of INR 0.557 million a year ago. Basic earnings per share from continuing operations was INR 1.01 compared to basic loss per share from continuing operations of INR 0.11 a year ago. For the full year, total revenue was INR 84.564 million compared to INR 48.61 million a year ago. Operating income was INR 22.545 million compared to INR 10.016 million a year ago. Net income was INR 14.497 million compared to INR 7.547 million a year ago. Basic earnings per share from continuing operations was INR 2.88 compared to INR 1.51 a year ago.